Global Early Commercial Strategy Lead – Rheumatology & Neuro
Pfizer Inc
A complete application in a minute
Tailored resume and cover letter, ready to send.
Benefits offered by this job
Job summary
Pfizer Inc. Global Commercial Strategy (GCS) seeks a Senior Manager for Early Commercial in Rheumatology, GI, and Neurology. You will shape long-range portfolio strategy, assess opportunities, and drive early product concepts with cross-functional teams across R&D, Medical Affairs, GASP, and Commercial Regions.
You will partner to translate scientific and market insights into actionable plans, enabling informed investment decisions and successful launches in a hybrid US-based role.
Qualifications
- Bachelor's degree required; MBA or advanced degree preferred
- 6+ years with BA/BS, 5+ years with MBA/MS, 1+ years with PhD/JD in pharma or related field
- Strong strategic and analytical skills; ability to synthesize complex information into recommendations
- Experience leading early commercial assessment, business case development, and cross-functional planning
- Excellent communication, executive presence, and stakeholder management
Responsibilities
- Lead early commercial assessments for pipeline assets and indications
- Develop and refine product concepts, target product profiles, and market hypotheses
- Provide commercial input to clinical development, evidence generation, and lifecycle discussions
- Drive cross-functional strategy, portfolio prioritization, and decision support
- Represent commercial perspective in external partnerships and internal governance
Skills
Education
Job description
Pfizer Inc. Global Commercial Strategy (GCS) seeks a Senior Manager for Early Commercial in Rheumatology, GI, and Neurology. You will shape long-range portfolio strategy, assess opportunities, and drive early product concepts with cross-functional teams across R&D, Medical Affairs, GASP, and Commercial Regions.
You will partner to translate scientific and market insights into actionable plans, enabling informed investment decisions and successful launches in a hybrid US-based role.
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
